4basebio PLC (88Q.DE) Stock Price
€10 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
7 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on 4basebio PLC, AI stock picks, stock alerts and much more.
88Q.DE AI Stock Analysis
AI stock analysis for 88Q.DE is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like 4basebio PLC (88Q.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
4basebio PLC (88Q.DE) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of 4basebio PLC (88Q.DE), currently trading at €10, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 88Q.DE
-
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms.
-
Symbol
88Q.DE
-
Market
XETRA
-
Industry
Biotechnology
-
Market Cap
154.8M
Similar Stocks
 |
CureVac 5CV.F |
€4.64 1% |
5 |
 |
BioNTech SE 22UA.F |
€95.8 0.2% |
5 |
 |
Novavax NVV1.F |
€6.74 1.8% |
3 |
 |
Heidelberg Pharma AG HPHA.DE |
€4.38 1.4% |
7 |
 |
Formycon AG FYB.DE |
€24.5 1.5% |
6 |
88Q.DE Alternative Data
Web Traffic
4basebio PLC receives an estimated 4408 monthly visitors to 4basebio.com.
-
Web Traffic
4408
-
Change from Previous Month
153.8%
-
3 Month Change
11.3%
-
YoY Change
11.3%
Youtube Subscribers
4basebio PLC has 31 subscribers on its main Youtube channel.
-
Youtube Subscribers
31
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
4basebio PLC has an estimated 0 open job postings, which is down -100% over the last month.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
-
YoY Change
100%
Reddit Mentions
4basebio PLC has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, 4basebio PLC has 131 employees, up by 1.6% over the last month.
-
LinkedIn Employees
131
-
Daily Change
1.6%
-
1 Month Change
1.6%
-
3 Month Change
5.6%
-
YoY Change
5.6%
Business Outlook
According to employee reviews, the business outlook among employees at 4basebio PLC is 100 out of 100 (very bullish).
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
4basebio PLC was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
88Q.DE Financials
88Q.DE Key Metrics
-
Total Revenue
£387.2K
-
Net Income
-£6.8M
-
Earnings per Share
-£0.53
-
Free cash flow
-£6.4M
-
EBITDA
-£6.2M
-
EBITDA Ratio
-16.1159
-
Total Assets
£11.9M
88Q.DE 2-year Revenue & Income
88Q.DE 2-year Free Cash Flow
88Q.DE Technicals
88Q.DE SMA
88Q.DE RSI
FAQ
What's the current price of 4basebio PLC (88Q.DE) Stock?
The price of an 4basebio PLC (88Q.DE) share is €10.
What's the market cap of 4basebio PLC?
The current market cap of 4basebio PLC is 154.8M.
Should I buy or sell 88Q.DE?
Multiple alternative data signals suggest that 4basebio PLC stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is 4basebio PLC a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in 4basebio PLC stock. The bullish indicators suggest that 4basebio PLC's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy 4basebio PLC (88Q.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying 4basebio PLC stock, given the bullish outlook.
What are some stocks similar to 4basebio PLC (88Q.DE) that investors often compare it to?
4basebio PLC (88Q.DE) is often compared to similar stocks such as CureVac, BioNTech SE, Novavax, Heidelberg Pharma AG and Formycon AG.
What is the forecast for 4basebio PLC's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast 4basebio PLC's stock price to be around €10.74 in 2026. Starting from the current price of €10, this represents a 7.4% change in price, indicating a bullish outlook for the stock.
How to buy 4basebio PLC (88Q.DE) Stock?
4basebio PLC stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy 4basebio PLC shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.